Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01786707 · ClinicalTrials.gov registry record · Phase 1
Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus
A Phase 1 study, sponsored by Rodolfo Alejandro.
- Completed
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT01786707: Completed Phase 1 study, sponsored by Rodolfo Alejandro.
NCT01786707 is a Phase 1 study that has completed, run by Rodolfo Alejandro. The registered enrollment target is 2 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01786707, a Phase 1 study, has completed, sponsored by Rodolfo Alejandro.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
A prospective, open labeled, randomized controlled clinical trial comparing the benefit of both hyperbaric oxygen therapy and intrapancreatic stem cell infusion to standard medical treatment alone for type 2 diabetes mellitus. Subjects will receive standard medical treatment (SMT) with insulin and metformin for 4 months (evaluation phase). Then they will be randomized into either the intervention group or the control group:
Interventions
- DRUG Metformin
- DRUG Insulin
- BIOLOGICAL Autologous stem cells
- OTHER Hyperbaric oxygen therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-07 |
| Est. Completion | 2013-03 |
| Phase | Phase 1 |
What the finished NCT01786707 record still lists
NCT01786707 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which Metformin is the first listed.
NCT01786707 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01786707 about?
NCT01786707 is a clinical study titled "Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus". A prospective, open labeled, randomized controlled clinical trial comparing the benefit of both hyperbaric oxygen therapy and intrapancreatic stem cell infusion to standard medical treatment alone for type 2 diabetes mellitus. Subjects will receive standard medical treatment (SMT) with insulin and m...
What is the current status of trial NCT01786707?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2009-07. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01786707?
The interventions under investigation include: Metformin (DRUG), Insulin (DRUG), Autologous stem cells (BIOLOGICAL), Hyperbaric oxygen therapy (OTHER).
Who is sponsoring clinical trial NCT01786707?
This trial is sponsored by Rodolfo Alejandro, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01786707's enrollment target sits among peer trials
2 2000th of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia